XML 30 R20.htm IDEA: XBRL DOCUMENT v3.25.3
10. STOCK-BASED COMPENSATION
6 Months Ended
Sep. 30, 2025
STOCK-BASED COMPENSATION  
NOTE 10 - STOCK-BASED COMPENSATION

NOTE 10—STOCK-BASED COMPENSATION

As of September 30, 2025, 2,354,451 shares of common stock were available for grant under the Company’s Amended and Restated 2016 Equity Incentive Plan.

The following table summarizes the Company’s stock option activities for the six months ended September 30, 2025:

Weighted

Number of Shares

Average

Weighted

Weighted

Shares

Underlying

Remaining

Average

Average Grant

Available for

Options

Contractual

Exercise

Date Fair

    

Grant

    

Outstanding

    

Life (Years)

    

Price

    

Value Per Share

Balance at March 31, 2025

3,095,976

7,636,716

$

5.03

$

2.11

Granted

(809,103)

809,103

$

3.85

$

3.01

Exercised

(13,375)

$

3.02

$

1.15

Forfeited

67,578

(413,066)

$

4.76

$

1.75

Balance at September 30, 2025

2,354,451

8,019,378

5.45

$

4.92

$

2.22

Options vested and exercisable

5,640,995

4.12

$

5.46

$

2.12

Options vested and expected to vest

7,966,254

5.43

$

4.93

$

2.22

Options unvested

2,378,383

8.60

$

3.66

$

2.46

The aggregate intrinsic value of options exercised during the six month period ended September 30, 2025 was $10,471.

The following table summarizes stock-based compensation expense by line item in the Condensed Consolidated Statements of Operations, all relating to employee stock plans:

Three Months Ended September 30, 

Six Months Ended September 30, 

2025

2024

2025

2024

(In thousands)

(In thousands)

Cost of revenues

$

58

$

51

$

102

$

107

Research and development

303

336

241

626

Selling, general and administrative

495

276

854

588

$

856

$

663

$

1,197

$

1,321